BPG is committed to discovery and dissemination of knowledge
Meta-Analysis
Copyright: ©Author(s) 2026.
World J Meta-Anal. Sep 18, 2026; 14(3): 121913
Published online Sep 18, 2026. doi: 10.13105/wjma.121913
Table 1 Characteristics of included trials
Ref.
Country
Number of recruited patients
Age in years
Female:Male
Duration of follow up
Trial running time
Farid et al[13], 2024EgyptLERV: 218; No LERV: 218LERV: 39.56 ± 12.31; No LERV: 44.44 ± 10.18LERV: 93:125; No LERV: 156:621 yearJanuary 2010 to April 2022
Lella et al[14], 2006ItalyLERV: 60; No LERV: 60LERV: 54.2 ± 9.51LERV: 33:27; No LERV: 35:2524 hoursJanuary 2002 to September 2004
Morino et al[15], 2006ItalyLERV: 46; No LERV: 45LERV: 56.6 ± 151; No LERV: 63.1 ± 14.51LERV: 31:15; No LERV: 25:2020 monthsMay 2001 to August 2005
Rábago et al[16], 2006SpainLERV: 64; No LERV: 59Not reportedNot reported24 monthsJune 1999 to June 2003
Sahoo et al[17], 2014IndiaLERV: 42; No LERV: 41LERV: 47.95 ± 13.51LERV: 53:3030 days2005 to 2012
Tzovaras et al[18], 2012GreeceLERV: 50; No LERV: 49LERV: 66 ± 16.251; No LERV: 69 ± 151LERV: 27:23; No LERV: 26:23Not reportedSeptember 2006 to April 2009


Write to the Help Desk